ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993

ACCC Presentations On Care In Community

March 27, 1981

FDA Discloses Avastin Regulatory History.

December 14, 2007

Kennedy Bill Leaves National Cancer Act intact, Creates NIH Construction Authority, Senior Service

April 1, 1988

NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion

November 4, 1994